Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
ZODIAC-16
Article Information
vol. 33 no. 2 322-326
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 28, 2009
- Accepted November 4, 2009
- Published in print January 26, 2010.
- Published online ahead of print November 16, 2009.
Article Versions
- Previous version (November 16, 2009 - 13:02).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2010 by the American Diabetes Association.
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Gijs W.D. Landman, MD1,2,
- Nanne Kleefstra, MD2,3,
- Kornelis J.J. van Hateren, MD2,
- Klaas H. Groenier, PHD4,
- Rijk O.B. Gans, MD, PHD5 and
- Henk J.G. Bilo, MD, PHD, FRCP2,5
- 1Internal Medicine, Isala Clinics, Zwolle, the Netherlands;
- 2Diabetes Centre, Isala Clinics, Zwolle, the Netherlands;
- 3Medical Research Group, Langerhans, Zwolle, the Netherlands;
- 4General Practice, University Medical Center Groningen, Groningen, the Netherlands;
- 5Internal Medicine, University Medical Center Groningen, Groningen, the Netherlands.
- Corresponding author: Gijs W.D. Landman, g.w.d.landman{at}isala.nl.
Statistics from Altmetric.com
Article usage
In this Issue
February 2010, 33(2)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes
